IDGXFIntegrated Diagnostics Holdings PLC.

About Integrated Diagnostics Holdings PLC. (IDGXF)

Integrated Diagnostics Holdings PLC. (IDGXF) is a Diagnostics & Research company headquartered in St. Helier, United Kingdom whose shares trade over-the-counter on the Pink tier.

IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria and is proudly woman-led. A long track record for quality and safety has earned the Group a trusted reputation, as well as internationally-recognised accreditations for its portfolio of over 1,400 diagnostics tests. From its base of over 452 branches, the Company will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. The Company aims to be a leading healthcare provider in every community and region that it serves, becoming every doctor and patient's first choice for quality, accurate diagnostic testing and cost effective services. One of IDH's philosophies is its strict adherence to providing accurate and timely diagnostic services, which is why we accredit our laboratories through stringent international bodies such as College of American Pathologists (CAP) and the International Organization for Standardization (ISO). The Company remains committed to its core values of providing patient-focused care, supporting and enhancing its medical staff's education and training, acquiring and sharing information effectively, while developing and strengthening its relationships with patients employees and business partners. IDH is also bound to its ethical values that emphasize integrity and fairness, as it strives for superior operational and financial performance.

IDGXF key facts

Ticker symbol

IDGXF

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

St. Helier, United Kingdom

Country of incorporation

GB

Estimated market cap

$192.00M (as of May 12, 2025)

Shares outstanding

600,000,000

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with I